Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers

Early personalized ctDNA study in gynecologic cancers showing that serial ctDNA dynamically predicted treatment response and survival.

PLoS OnePubMed 26717006DOI 10.1371/journal.pone.0145754